We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01222338
Recruitment Status : Completed
First Posted : October 18, 2010
Last Update Posted : August 3, 2012
National Medical University, Ukraine
Immunitor USA Inc.
Information provided by (Responsible Party):
Lisichansk Regional Tuberculosis Dispensary